DE69118526D1 - Mittel zur transdermalen penetration von arzneimitteln - Google Patents

Mittel zur transdermalen penetration von arzneimitteln

Info

Publication number
DE69118526D1
DE69118526D1 DE69118526T DE69118526T DE69118526D1 DE 69118526 D1 DE69118526 D1 DE 69118526D1 DE 69118526 T DE69118526 T DE 69118526T DE 69118526 T DE69118526 T DE 69118526T DE 69118526 D1 DE69118526 D1 DE 69118526D1
Authority
DE
Germany
Prior art keywords
agents
medicinal products
transdermal penetration
transdermal
penetration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69118526T
Other languages
English (en)
Other versions
DE69118526T2 (de
Inventor
Richard Ferber
Scott Burton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Co
Original Assignee
Minnesota Mining and Manufacturing Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minnesota Mining and Manufacturing Co filed Critical Minnesota Mining and Manufacturing Co
Application granted granted Critical
Publication of DE69118526D1 publication Critical patent/DE69118526D1/de
Publication of DE69118526T2 publication Critical patent/DE69118526T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69118526T 1990-04-27 1991-04-16 Mittel zur transdermalen penetration von arzneimitteln Expired - Fee Related DE69118526T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/515,198 US5149719A (en) 1990-04-27 1990-04-27 Composition for transdermal penetration of medicaments
PCT/US1991/002582 WO1991016930A1 (en) 1990-04-27 1991-04-16 Composition for transdermal penetration of medicaments

Publications (2)

Publication Number Publication Date
DE69118526D1 true DE69118526D1 (de) 1996-05-09
DE69118526T2 DE69118526T2 (de) 1996-11-21

Family

ID=24050351

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69118526T Expired - Fee Related DE69118526T2 (de) 1990-04-27 1991-04-16 Mittel zur transdermalen penetration von arzneimitteln

Country Status (7)

Country Link
US (1) US5149719A (de)
EP (1) EP0526561B1 (de)
JP (1) JPH05507502A (de)
AU (1) AU648794B2 (de)
DE (1) DE69118526T2 (de)
IE (1) IE75700B1 (de)
WO (1) WO1991016930A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5316768A (en) 1990-12-28 1994-05-31 Murdock International Corporation Pharmaceutical compositions having antiviral activity against human cytomegalovirus
US5861439A (en) * 1994-11-14 1999-01-19 Alza Corporation Method for enhanced electrotransport agent delivery
US5736580A (en) * 1994-11-14 1998-04-07 Alza Croporation Composition, device, and method for electrotransport agent delivery
US6623744B2 (en) * 1995-06-22 2003-09-23 3M Innovative Properties Company Stable hydroalcoholic compositions
EP0833605A1 (de) * 1995-06-22 1998-04-08 Minnesota Mining And Manufacturing Company Stablie alkoholisch-wässrige zusammensetzung
DE69630221T2 (de) * 1995-06-22 2004-07-15 Minnesota Mining And Mfg. Co., Saint Paul Stabile alkoholisch-wässrige zusammensetzung
US7566460B2 (en) * 1995-06-22 2009-07-28 3M Innovative Properties Company Stable hydroalcoholic compositions
US6582711B1 (en) 1997-01-09 2003-06-24 3M Innovative Properties Company Hydroalcoholic compositions thickened using polymers
US6019997A (en) * 1997-01-09 2000-02-01 Minnesota Mining And Manufacturing Hydroalcoholic compositions for transdermal penetration of pharmaceutical agents
US5908619A (en) * 1997-01-09 1999-06-01 Minnesota Mining And Manufacturing Company Hydroalcoholic compositions thickened using surfactant/polymer complexes
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
ATE537836T1 (de) * 2002-05-02 2012-01-15 E L Management Corp Verfahren zur verbesserung der biologischen aktivität von pflanzenextrakten
US8790689B2 (en) * 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
PE20081297A1 (es) 2003-04-30 2008-09-17 Purdue Pharma Lp Forma de dosificacion transdermica resistente a la manipulacion
BRPI0414551B8 (pt) 2003-10-10 2021-05-25 Antares Pharma Ipl Ag formulação farmacêutica transdérmica ou transmucosa e método de protelação ou inibição da cristalização de um agente ativo
WO2006031856A2 (en) 2004-09-13 2006-03-23 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
US8252319B2 (en) 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
US8246977B2 (en) 2004-10-21 2012-08-21 Durect Corporation Transdermal delivery systems
US8372040B2 (en) 2005-05-24 2013-02-12 Chrono Therapeutics, Inc. Portable drug delivery device including a detachable and replaceable administration or dosing element
WO2006125642A1 (en) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
US8053000B2 (en) 2005-06-07 2011-11-08 Dr. Reddy's Laboratories Limited Compositions for drug delivery
JP5058531B2 (ja) * 2005-09-09 2012-10-24 日東電工株式会社 ビソプロロール含有貼付製剤
JP4945228B2 (ja) * 2005-12-13 2012-06-06 日東電工株式会社 ビソプロロール含有貼付製剤
CN101426475A (zh) 2006-04-21 2009-05-06 安塔雷斯制药Ipl股份公司 使用用于经皮或经粘膜应用的制剂治疗热潮红的方法
US8703178B2 (en) * 2007-03-08 2014-04-22 Nitto Denko Corporation Percutaneous administration device of bisoprolol
CA2841785A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
CA2974324A1 (en) 2015-01-28 2016-08-04 Zita S. Netzel Drug delivery methods and systems
JP2018511127A (ja) 2015-03-12 2018-04-19 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 渇望入力及び支援システム
WO2018129304A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321257A (en) * 1974-07-08 1982-03-23 Johnson & Johnson Potentiated medicaments
US4006218A (en) * 1974-07-08 1977-02-01 Johnson & Johnson Potentiated medicaments
GB2075837B (en) * 1980-05-14 1984-03-14 Hisamitsu Pharmaceutical Co Topical pharmaceutical gel containing anti-inflammatory analgesic agents
CA1165240A (en) * 1980-07-09 1984-04-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
FR2502951B1 (fr) * 1981-04-06 1985-12-06 Sandoz Sa Compositions pharmaceutiques topiques sous forme d'une micro-emulsion
JPS5855411A (ja) * 1981-09-28 1983-04-01 Nitto Electric Ind Co Ltd 基剤組成物および外用医薬組成物
CH655656B (de) * 1982-10-07 1986-05-15
DK243084A (da) * 1983-05-26 1984-11-27 Takeda Chemical Industries Ltd Perkutane farmaceutiske praeparater til udvortes brug
US4752612A (en) * 1983-07-01 1988-06-21 Nitto Electrical Industrial Co., Ltd. Method and percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4615699A (en) * 1985-05-03 1986-10-07 Alza Corporation Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes
US4645502A (en) * 1985-05-03 1987-02-24 Alza Corporation Transdermal delivery of highly ionized fat insoluble drugs
JPH072628B2 (ja) * 1986-03-31 1995-01-18 日東電工株式会社 養毛組成物
JPS6335521A (ja) * 1986-07-30 1988-02-16 Nitto Electric Ind Co Ltd 医薬製剤
ZA875317B (en) * 1986-08-01 1988-01-25 Warner-Lambert Company Transdermal compositions
JPS6351326A (ja) * 1986-08-22 1988-03-04 Nisshin Flour Milling Co Ltd ニコランジル外用剤
MY102980A (en) * 1986-10-31 1993-03-31 Pfizer Transdermal flux enhancing compositions
DE3779999T2 (de) * 1986-11-14 1992-12-10 Theratech Inc Erhoehung des penetrationsvermoegens mittels eines aus die zellhuelle veraendernden substanzen und kurzkettigen alkoholen bestehenden binaeren systems.

Also Published As

Publication number Publication date
AU648794B2 (en) 1994-05-05
US5149719A (en) 1992-09-22
DE69118526T2 (de) 1996-11-21
AU7781691A (en) 1991-11-27
WO1991016930A1 (en) 1991-11-14
IE75700B1 (en) 1997-09-10
IE911281A1 (en) 1991-11-06
EP0526561A1 (de) 1993-02-10
JPH05507502A (ja) 1993-10-28
EP0526561B1 (de) 1996-04-03

Similar Documents

Publication Publication Date Title
DE69118526T2 (de) Mittel zur transdermalen penetration von arzneimitteln
DE3762480D1 (de) Mittel zur applikation von transdermal resorbierbaren wirkstoffen.
ATE181824T1 (de) Mittel zur feuchthaltung von gewebe und verfahren
DE3787377D1 (de) Eindringungserhöhende mittel zur transdermalen verabreichung systemischer mittel.
DE69530004D1 (de) Transdermale verabreichung von apomorphin
DE3588190T2 (de) Vorrichtung zur transdermalen Applikation von Medikamenten
DE69008664D1 (de) Bestrahlung von bluterzeugnissen.
DE69122494T2 (de) Vorrichtung zur transdermalen Applikation von Protein- oder Peptid-Medikamenten
DE69719761D1 (de) Vorrichtung zur verbesserung der transdermalen verabreichung von medikamenten oder der abnahme von körperflüssigkeiten
DE69631531D1 (de) Katheter zur verabreidung von arzneien
DK316988D0 (da) Transdermalt farmaceutisk praeparat og dets anvendelse
DK153787D0 (da) Laegemidler med langsom frigivelse
ATA11989A (de) Mittel zur vorbeugung gegen und behandlung von parodontopathien
DE69513672T2 (de) Verbesserte vorrichtung zur iontophoretischen verabreichung von medikamenten
DE59500266D1 (de) Transdermales therapeutisches System zur Applikation von Naloxon
DE3676601D1 (de) Mittel zur injektion von aktiviertem vitamin-d3.
DE3669886D1 (de) Produkte und verfahren zum behandeln von geweben.
ATE292457T1 (de) Mittel und verfahren zur transdermalen verabreichung säurelabiler arzneistoffe
DE3583234D1 (de) Physiologische mittel zur steigerung der transdermalen freisetzung von arzneimitteln.
DE69028520D1 (de) Arzneimittelzubereitung bei der behandlung von tonsillitis
DE9409784U1 (de) Vorrichtung zur transdermalen Applikation von Wirkstoffen
ATE53767T1 (de) Mittel zur applikation von transdermal resorbierbaren wirkstoffen.
DE68908445T2 (de) Mittel zur Behandlung von Lebererkrankungen.
DE3855561D1 (de) Mittel zur verhütung von zahnbelag und belagabhängigen krankheiten
DK429589D0 (da) Transdermalt laegemiddelpraeparat

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee